Navigation Links
Leading virologists join together to tackle viruses, leukemia and neurologic disorders
Date:6/17/2014

The Global Virus Network (GVN) announced today the launch of a Task Force on HTLV, Human T-Lymphotropic Virus (HTLV), the world's first known human retrovirus and only known leukemia-causing virus. Experts from 11 countries*, led by Dr. Robert Gallo, GVN co-founder and scientific director and director of the Institute of Human Virology (IHV) at the University of Maryland School of Medicine, Dr. Luc Willems (Research Director, National Fund for Scientific Research at University of Lige) and Dr. Hideki Hasegawa (Director, Department of Pathology, National Institute of Infectious Diseases, Japan) are leading the Task Force, which met for the first time last month.

"There are no effective vaccines against HTLV, no antiviral drugs to treat infections, and though there are diagnostic tests for the virus none yet can predict which infected person gets disease," said Dr. Gallo who pioneered the field of human retrovirology with his groundbreaking discoveries of HTLV- 1 in 1980 and HTLV-2 in 1982. "This Task Force is critical as the global community works together to address a problem which in many countries is under-recognized and under-appreciated," he continued.

More than 20 million people worldwide are infected with the virus, of which up to 10% will develop debilitating and sometimes deadly disease. HTLV causes an adult T-cell leukemia/ lymphoma (ATL), HTLV-associated myelopathy (HAM), spastic paraparesis, and other rare illnesses. Signs and symptoms of HTLV infection include motor and sensory changes in the extremities, inflammation in the spinal cord, a spastic gait in combination with weakness of the lower limbs, cognitive impairment, bladder dysfunction and bladder cancer. HTLV, similar to the human immunodeficiency virus (HIV), also co-discovered by Dr. Gallo as the cause of AIDS, is transmitted through sexual contact, from mother to child via breastfeeding, and through exposure to contaminated blood.

"This task force is to set the common goal among the scientists around the world to accelerate the research in order to overcome HTLV and related diseases," said Dr. Hideki Hasegawa of Japan's National Institute of Infectious Diseases.

The mission of the HTLV Task Force is to speed the pathway to discovery of drugs that will stop virus transmission or progression from infection to disease, in addition to educating the public about the nature of these viruses, the diseases they cause, and how to prevent their spread.

Dr. Sharon Hrynkow, President of GVN, concluded, "We are excited to be able to bring together leading experts to mobilize more research and more attention to HTLV by governments in order to help communities most affected by this insidious virus."


'/>"/>

Contact: Nora Grannell
ngrannell@gvn.org
410-706-1966
Global Virus Network
Source:Eurekalert

Related biology news :

1. Leading cfaed scientists organize international workshop about DNA-based microchips
2. Synaptics to Showcase Industry-Leading Human Interface Solutions At 2014 Consumer Electronics Show
3. Uncovering first molecular missteps that drive neurons in pathway leading to Alzheimers disease
4. IU-designed probe opens new path for drug development against leading STD
5. First International Bioenergy Conference brings together world-leading experts
6. Genetic signature identified for RSV, the leading cause of infant hospitalizations worldwide
7. Leading Pharma Company Selects Clinilabs to Conduct a Phase 1 Study of an Investigational Type 2 Diabetes Medication
8. RIKEN and leading Indian institutions launch Joint Research Centers
9. Marvin Test Solutions Featured at AUTOTESTCON 2013 with Leading Armament Experts and Test Systems
10. FPC Awarded new Smartphone DW From Existing Prominent Asian OEM Customer for Launch With Leading US Operator
11. Join Leading Organizations at Biodetection Technologies 2013 in Alexandria, VA from June 18-19, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2016)... A market that just keeps on growing. ... explosion in genomics knowledge. Learn all about it in ... of dynamic trends are pushing market growth and company ... pharmacogenomics - pathogen evolution - next generation sequencing - ... understanding of the role of genetic material in Disease ...
(Date:1/20/2016)... SAN JOSE, Calif. , Jan. 20, 2016 ... leading developer of human interface solutions, today announced ... touch controller solution for wearables and small screen ... appliances such as printers. Supporting round and rectangular ... the S1423 offers excellent performance with moisture on ...
(Date:1/15/2016)... , Jan. 15, 2016 Recent publicized breaches ... to find new ways to ensure data security and ... iOS and Android that ties a ... transforming it into a hardware authorization token. Customer service ... their fingerprint on their KodeKey enabled device to verify ...
Breaking Biology News(10 mins):
(Date:2/11/2016)... WASHINGTON , Feb. 11, 2016   BioInformant ... strategic report, "Stem Cell Research Products, Opportunities, Tools, and ... 2020. ... specialize in the stem cell industry, BioInformant has more ... of the stem cell market, by stem cell type. ...
(Date:2/11/2016)... ... 2016 , ... Global Stem Cells Group, has ... The new facility will provide advanced protocols and state-of-the-art techniques in cellular medicine, ... , The new GSCG clinic is headed by four prominent Ecuadorian physicians, including ...
(Date:2/10/2016)... Md. , Feb. 10, 2016  The Maryland ... Busch , has announced that University of Maryland School ... PhD, MBA and University of Maryland Medical System President ... of the "Speaker,s Medallion," the highest honor given to ... of Delegates. Dean Reece and Mr. ...
(Date:2/10/2016)... and New York, New York (PRWEB) , ... ... ... Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) today announced that it has joined ... new vaccines and immunotherapies for infectious diseases and cancer. , The ...
Breaking Biology Technology: